Recursion

Recursion Pharmaceuticals is a clinical-stage TechBio company based in Salt Lake City, Utah, founded in 2013. The company specializes in AI-driven drug discovery, utilizing a combination of experimental biology, automated labs, and extensive datasets to develop new medicines for diseases with significant unmet needs, including aggressive cancers and rare diseases. Their innovative Recursion Operating System (OS) integrates various biological data types and aims to reduce the traditional drug failure rate and shorten discovery timelines. The Recursion OS supports the entire drug discovery process, from identifying potential drug candidates to conducting studies necessary for regulatory approval. The company employs automated wet labs and advanced AI and machine learning techniques to analyze cellular disruptions and design molecules. With powerful computational resources, including the BioHive-2 supercomputer, Recursion processes vast amounts of data to enhance its drug development pipeline. The company collaborates with leading pharmaceutical and technology partners to further its mission of accelerating the discovery of effective treatments.